Come up with a name for your new list and we'll add to it:
Tesaro raised a round of funding on May 13, 2010. Investors include
New Enterprise Associates.
Tesaro is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to identify, acquire and develop promising drug candidates; and to comm…